Ocean Biomedical Stock Market Value
| OCEAW Stock | 0.04 0 9.77% |
| Symbol | Ocean |
Ocean Biomedical Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocean Biomedical. If investors know Ocean will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocean Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Ocean Biomedical is measured differently than its book value, which is the value of Ocean that is recorded on the company's balance sheet. Investors also form their own opinion of Ocean Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Ocean Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocean Biomedical's market value can be influenced by many factors that don't directly affect Ocean Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocean Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocean Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocean Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Ocean Biomedical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ocean Biomedical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ocean Biomedical.
| 10/31/2024 |
| 11/30/2024 |
If you would invest 0.00 in Ocean Biomedical on October 31, 2024 and sell it all today you would earn a total of 0.00 from holding Ocean Biomedical or generate 0.0% return on investment in Ocean Biomedical over 30 days. Ocean Biomedical is related to or competes with Tff Pharmaceuticals, Eliem Therapeutics, Inhibrx, Enliven Therapeutics, and Molecular Partners. Ocean Biomedical is entity of United States More
Ocean Biomedical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ocean Biomedical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ocean Biomedical upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 14.1 | |||
| Information Ratio | 0.0761 | |||
| Maximum Drawdown | 211.06 | |||
| Value At Risk | (23.47) | |||
| Potential Upside | 29.32 |
Ocean Biomedical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ocean Biomedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ocean Biomedical's standard deviation. In reality, there are many statistical measures that can use Ocean Biomedical historical prices to predict the future Ocean Biomedical's volatility.| Risk Adjusted Performance | 0.0718 | |||
| Jensen Alpha | 2.34 | |||
| Total Risk Alpha | (2.31) | |||
| Sortino Ratio | 0.1445 | |||
| Treynor Ratio | (1.58) |
Ocean Biomedical Backtested Returns
Ocean Biomedical appears to be out of control, given 3 months investment horizon. Ocean Biomedical maintains Sharpe Ratio (i.e., Efficiency) of 0.0532, which implies the firm had a 0.0532% return per unit of risk over the last 3 months. By analyzing Ocean Biomedical's technical indicators, you can evaluate if the expected return of 0.8% is justified by implied risk. Please evaluate Ocean Biomedical's Risk Adjusted Performance of 0.0718, semi deviation of 12.61, and Coefficient Of Variation of 1231.06 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Ocean Biomedical holds a performance score of 4. The company holds a Beta of -1.37, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Ocean Biomedical are expected to decrease by larger amounts. On the other hand, during market turmoil, Ocean Biomedical is expected to outperform it. Please check Ocean Biomedical's total risk alpha and the relationship between the potential upside and day typical price , to make a quick decision on whether Ocean Biomedical's historical price patterns will revert.
Auto-correlation | 0.15 |
Insignificant predictability
Ocean Biomedical has insignificant predictability. Overlapping area represents the amount of predictability between Ocean Biomedical time series from 31st of October 2024 to 15th of November 2024 and 15th of November 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ocean Biomedical price movement. The serial correlation of 0.15 indicates that less than 15.0% of current Ocean Biomedical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.15 | |
| Spearman Rank Test | 0.57 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Ocean Biomedical lagged returns against current returns
Autocorrelation, which is Ocean Biomedical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Ocean Biomedical's stock expected returns. We can calculate the autocorrelation of Ocean Biomedical returns to help us make a trade decision. For example, suppose you find that Ocean Biomedical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Ocean Biomedical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Ocean Biomedical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Ocean Biomedical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Ocean Biomedical stock over time.
Current vs Lagged Prices |
| Timeline |
Ocean Biomedical Lagged Returns
When evaluating Ocean Biomedical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Ocean Biomedical stock have on its future price. Ocean Biomedical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Ocean Biomedical autocorrelation shows the relationship between Ocean Biomedical stock current value and its past values and can show if there is a momentum factor associated with investing in Ocean Biomedical.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Ocean Stock Analysis
When running Ocean Biomedical's price analysis, check to measure Ocean Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocean Biomedical is operating at the current time. Most of Ocean Biomedical's value examination focuses on studying past and present price action to predict the probability of Ocean Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocean Biomedical's price. Additionally, you may evaluate how the addition of Ocean Biomedical to your portfolios can decrease your overall portfolio volatility.